학술논문

Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period
Document Type
ConferencePaper
Source
HORMONE RESEARCH IN PAEDIATRICS. 95(SUPPL 2):29-30
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1663-2818